Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,023 | -47,667 | -32,718 | -6,701 | N/A |
| Depreciation Amortization | 1,328 | 1,087 | 799 | 651 | N/A |
| Accounts payable and accrued liabilities | 281 | 46 | -91 | -219 | N/A |
| Other Working Capital | -3,286 | 5,852 | 1,018 | -473 | N/A |
| Other Operating Activity | 3,748 | -143 | 2,344 | -2,502 | 0 |
| Operating Cash Flow | $-49,952 | $-40,825 | $-28,648 | $-9,244 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 14,001 | -13,992 | N/A |
| PPE Investments | -2,340 | -1,409 | -1,484 | -241 | N/A |
| Other Investing Activity | 1,059 | -631 | -608 | -355 | 0 |
| Investing Cash Flow | $-1,281 | $-2,040 | $11,909 | $-14,588 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 6,934 | N/A |
| Debt Repayment | N/A | N/A | N/A | -533 | N/A |
| Common Stock Issued | 32,704 | 88,751 | 362 | 0 | N/A |
| Other Financing Activity | -283 | 18,167 | 50,083 | 21,100 | 0 |
| Financing Cash Flow | $32,421 | $106,918 | $50,445 | $27,501 | $N/A |
| Exchange Rate Effect | -10 | -1 | 3 | 5 | N/A |
| Beginning Cash Position | 102,238 | 38,186 | 4,477 | 803 | N/A |
| End Cash Position | 83,416 | 102,238 | 38,186 | 4,477 | N/A |
| Net Cash Flow | $-18,822 | $64,052 | $33,709 | $3,674 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,952 | -40,825 | -28,648 | -9,244 | N/A |
| Capital Expenditure | -2,340 | -1,409 | -1,484 | -261 | N/A |
| Free Cash Flow | -52,292 | -42,234 | -30,132 | -9,505 | 0 |